Post-TAVR patients with atrial fibrillation: are NOACs better than VKAs?—A meta-analysis

Post-TAVR patients with atrial fibrillation: are NOACs better than VKAs?—A meta-analysis

ObjectiveThis study aimed to compare the efficacy of novel oral anticoagulants (NOACs) with traditional anticoagulants vitamin K antagonists (VKAs) in patients with atrial fibrillation (AF) post transcatheter aortic valve replacement (TAVR).MethodsStudies comparing the usage of NOACs and VKAs in AF...

Full description

Bibliographic Details
Main Authors: Lu Wang, Wanyue Sang, Yi Jian, Xiaoxue Zhang, Yafan Han, Feifei Wang, Liang Wang, Suxia Yang, Subinuer Wubulikasimu, Li Yang, Huaxin Sun, Yaodong Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-08-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
transcatheter aortic valve replacement
atrial fibrillation
anticoagulant therapy
new oral anticoagulants
vitamin K antagonists
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2023.1175215/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2023.1175215/full

Similar Items